These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 26731696

  • 1. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.
    Ghoshal UC, Srivastava D, Misra A, Ghoshal U.
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):281-9. PubMed ID: 26731696
    [Abstract] [Full Text] [Related]

  • 2. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.
    Ghoshal UC, Srivastava D, Ghoshal U, Misra A.
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):753-60. PubMed ID: 24849768
    [Abstract] [Full Text] [Related]

  • 3. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.
    Tuteja AK, Talley NJ, Stoddard GJ, Verne GN.
    Dig Dis Sci; 2019 Mar; 64(3):838-845. PubMed ID: 30370492
    [Abstract] [Full Text] [Related]

  • 4. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
    Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M.
    Gut; 2007 Jun; 56(6):802-8. PubMed ID: 17148502
    [Abstract] [Full Text] [Related]

  • 5. Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.
    Moraru IG, Moraru AG, Andrei M, Iordache T, Drug V, Diculescu M, Portincasa P, Dumitrascu DL.
    Rom J Intern Med; 2014 Jun; 52(3):143-50. PubMed ID: 25509557
    [Abstract] [Full Text] [Related]

  • 6. Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study.
    Moraru IG, Portincasa P, Moraru AG, Diculescu M, Dumitraşcu DL.
    Rom J Intern Med; 2013 Jun; 51(3-4):143-7. PubMed ID: 24620626
    [Abstract] [Full Text] [Related]

  • 7. Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial.
    Majewski M, McCallum RW.
    Adv Med Sci; 2007 Jun; 52():139-42. PubMed ID: 18217406
    [Abstract] [Full Text] [Related]

  • 8. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ, Wei H, Duan LP, Zhu SW, Zhang L, Wang K.
    Zhonghua Yi Xue Za Zhi; 2016 Jun 28; 96(24):1896-902. PubMed ID: 27373356
    [Abstract] [Full Text] [Related]

  • 9. A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome.
    Ghoshal UC, Nehra A, Mathur A, Rai S.
    J Gastroenterol Hepatol; 2020 Jun 28; 35(6):922-931. PubMed ID: 31750966
    [Abstract] [Full Text] [Related]

  • 10. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.
    Ghoshal UC, Shukla R, Ghoshal U.
    Gut Liver; 2017 Mar 15; 11(2):196-208. PubMed ID: 28274108
    [Abstract] [Full Text] [Related]

  • 11. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.
    Zhao J, Zheng X, Chu H, Zhao J, Cong Y, Fried M, Fox M, Dai N.
    Neurogastroenterol Motil; 2014 Jun 15; 26(6):794-802. PubMed ID: 24641100
    [Abstract] [Full Text] [Related]

  • 12. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.
    Lombardo L, Foti M, Ruggia O, Chiecchio A.
    Clin Gastroenterol Hepatol; 2010 Jun 15; 8(6):504-8. PubMed ID: 20060064
    [Abstract] [Full Text] [Related]

  • 13. Glucose hydrogen breath test for small intestinal bacterial overgrowth in children with abdominal pain-related functional gastrointestinal disorders.
    Korterink JJ, Benninga MA, van Wering HM, Deckers-Kocken JM.
    J Pediatr Gastroenterol Nutr; 2015 Apr 15; 60(4):498-502. PubMed ID: 25406525
    [Abstract] [Full Text] [Related]

  • 14. Microscopic colitis and small intestinal bacterial overgrowth--diagnosis behind the irritable bowel syndrome?
    Stoicescu A, Andrei M, Becheanu G, Stoicescu M, Nicolaie T, Diculescu M.
    Rev Med Chir Soc Med Nat Iasi; 2012 Apr 15; 116(3):766-72. PubMed ID: 23272525
    [Abstract] [Full Text] [Related]

  • 15. Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype.
    Ghoshal UC, Srivastava D.
    World J Gastroenterol; 2014 Mar 14; 20(10):2482-91. PubMed ID: 24627585
    [Abstract] [Full Text] [Related]

  • 16. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
    Yang M, Zhang L, Hong G, Li Y, Li G, Qian W, Xiong H, Bai T, Song J, Hou X.
    J Gastroenterol Hepatol; 2020 May 14; 35(5):795-805. PubMed ID: 31674052
    [Abstract] [Full Text] [Related]

  • 17. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
    Rana SV, Sharma S, Kaur J, Sinha SK, Singh K.
    Digestion; 2012 May 14; 85(3):243-7. PubMed ID: 22472730
    [Abstract] [Full Text] [Related]

  • 18. Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain.
    Collins BS, Lin HC.
    J Pediatr Gastroenterol Nutr; 2011 Apr 14; 52(4):382-6. PubMed ID: 21240023
    [Abstract] [Full Text] [Related]

  • 19. Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.
    Leventogiannis K, Gkolfakis P, Spithakis G, Tsatali A, Pistiki A, Sioulas A, Giamarellos-Bourboulis EJ, Triantafyllou K.
    Probiotics Antimicrob Proteins; 2019 Jun 14; 11(2):627-634. PubMed ID: 29508268
    [Abstract] [Full Text] [Related]

  • 20. Evaluating a bacterial hypothesis in IBS using a modification of Koch's postulates: part 1.
    Pimentel M.
    Am J Gastroenterol; 2010 Apr 14; 105(4):718-21. PubMed ID: 20372119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.